Plasma concentrations of E-selectin, ICAM-1, and VCAM-1 as markers of endothelial dysfunction were proven to predict development of T2D in initially nondiabetic women [21], and the association was independent of other known risk factors such as subclinical inflammation and obesity. The gene discussed is SELE; the disease is endothelial dysfunction.